- Home
- LNTH vs PLXS Comparison
LNTH vs PLXS Comparison
Compare LNTH & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | PLXS |
|---|---|---|
| Founded | 1956 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.0B |
| IPO Year | 2015 | 1986 |
Fundamental Metrics
Financial Performance| Metric | LNTH | PLXS |
|---|---|---|
| Price | $69.66 | $157.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $78.00 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 1.1M | 192.2K |
| Earning Date | 02-25-2026 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.11 |
| EPS | 2.39 | ★ 6.26 |
| Revenue | $1,525,933,000.00 | ★ $4,032,966,000.00 |
| Revenue This Year | $0.01 | $10.99 |
| Revenue Next Year | $0.52 | $7.02 |
| P/E Ratio | $28.83 | ★ $24.54 |
| Revenue Growth | ★ 1.95 | 1.82 |
| 52 Week Low | $47.25 | $103.43 |
| 52 Week High | $111.29 | $172.89 |
Technical Indicators
Market Signals| Indicator | LNTH | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 58.66 |
| Support Level | $66.36 | $146.81 |
| Resistance Level | $67.45 | $157.63 |
| Average True Range (ATR) | 1.69 | 4.73 |
| MACD | -0.01 | -0.33 |
| Stochastic Oscillator | 93.81 | 66.52 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.